A Message from our CEO/Executive Director
David and Goliath.
A Tribute to Debbie Markham
David and Goliath.
This is an ironic time of year.
It’s so amazing how quickly summer seemed to fly by.
“The dog days of summer”
How did it get to be June so quickly?
May 7th we are excited to host our Ribbons and Roses fundraiser at the Lamar Street Center.
“There is no luck except where there is discipline.”
The Dalai Lama once said “Love and compassion are necessities, not luxuries. Without them, humanity cannot survive.”
We couldn’t do this important work without you – thank you very much!
WSCR-NCORP is putting compassion first with the creation of our Implicit Bias in Healthcare steering committee.
Greetings and Happy New year.
I hope you and your loved ones had a restive and festive holiday season.
While it’s always difficult to get back in the groove after time away from the office, having good things to look forward to makes the transition back to work so much easier…and we at WSCR-NCORP have a lot to be excited about in 2023.
First, we are fully staffed for the first time in several months which means we can function more efficiently. In October Aleisha Hardiman joined our team as a QA Specialist, and over the holiday, we hired Libby Koch as our Research Assistant who will lead our efforts with the TMIST study. We are thrilled to have both of them on board.
The timing couldn’t be better to have a full staff because our NCORP is growing in more ways than one. In December we brought on a new site partner: Mercy Health in Paducah, KY. We are very excited about this new partnership as it allows us to bring clinical trials to a community that has long desired to have such access, and the team at Mercy is thrilled to have us managing the studies their physicians want to bring to their patients.
Additionally, here in Colorado, we are beginning discussions with a site on the Western Slope that is interested in bringing clinical trial opportunities to their patients.
Being able to open studies at both Mercy Health and the prospective site here in Colorado will allow us to further our mission of bringing clinical trials to rural and underserved populations.
We are also experiencing growth in the array of studies we can offer our physicians, and by extension, their patients. Over the course of the next month, we will be opening three new industry studies in addition to four other pharmaceutical studies that are currently active. And as always, we have 80+ NCI studies open.
So, 2023 truly is shaping up to be a very exciting time in the life of our NCORP. I am so grateful to be first among equals on our team of qualified, passionate, and compassionate colleagues. We have a lot of work ahead of us, but hard work is always easier when done with the right people.
Here’s to a new year of expansion and innovation which means new opportunities for our physicians, our patients, and their families.
Yours in good health,